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Abstract–This study aims to analyze the effect of Corporate Social Responsibility on firm value, 
the size of the company against firm value, profitability against firm value, company size in 
moderating the relationship between Corporate Social Responsibility and company value, 
profitability in moderating the relationship between Corporate Social Responsibility to the value 
of the company. This study uses a quantitative method which uses time series or past data related 
to the Annual Report of Pharmaceutical Companies listed on the  Indonesia Stock Exchange. 
The technical data analysis in this study uses Analysis Moderated Regresion with SPSS for 
Windows 25.0. The sample in this study used eight pharmaceutical companies listed on the 
Indonesia Stock Exchange. Use annual reports with the 2014-2017 period. The results of the 
research obtained are Corporate Social Responsibility has a significant positive effect on firm 
value,Firm size has a significant positive effect on firm value, Profitability has a significant 
negative effect on firm value, Firm size is not able to moderate relationships between Corporate 
Social Responsibility (CSR) and company value, Profitability is not able to moderate the 
relationship between Corporate Social Responsibility (CSR) and company value. 
Keywords: Company size, Corporate Social Responsibility, Profitability, Return On Assets 
(ROA), Tobins’Q. 
INTRODUCTION  
Company value is the most important 
thing that must be obtained by the company to 
the maximum. The maximum assessment of a 
company can be seen from its ability to survive 
in the company's survival, so that the 
company's value can be maintained properly 
(Rumajar, 2018). The value of the company 
relates to profits and increases in stock prices, 
as well as the ups and downs of market share 
conditions that are automatically related to the 
rate of growth and the value of the company. 
One of the things that can be seen is 
pharmaceutical companies. Pharmaceutical 
companies are companies that are very active 
in the field of health support. However, 
pharmaceutical companies experienced a 
decline in share prices, for example Kalbe 
Farma Tbk in 2016 which increased by 1,515 
rupiah and decreased in 2017 by 1,380 rupiah. 
In addition, Kimia Farma (Persero) Tbk 
experienced an increase in 2016 of 2,750 
rupiah and decreased in 2017 by 2,550 rupiah. 
Something similar happened to Merck Tbk and 
Tempo Scan Pacific Tbk which decreased in 
2017 by 5,700 rupiah and 1,405 rupiah. The 
result is a slow growth rate in pharmaceutical 
companies where the Industry Development 
Analysis Edition II-2018 by the Ministry of 
Industry of the Republic of Indonesia that in 
2015-2016 always recorded the highest 
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growth, but in the fourth quarter of 2017 there 
was a decrease of 5.46% to contraction in the 
amount of 6.30% in the first quarter of 2018. 
Thus, optimization is needed in upholding 
company valuation, so additional information 
is needed related to corporate social 
responsibility, namely Corporate Social 
Responsibility. 
Corporate Social Responsibility is a 
concept of corporate responsibility committed 
to contributing to sustainable economic 
development looking at the balance of social, 
economic and environmental aspects. 
Corporate Social Responsibility is a mandatory 
thing to be carried out in accordance with Law 
Number 40 of 2007. However, (Widokarti, 
2014) states that the fundamental problem that 
occurs is the distribution and management of 
CSR funds in Indonesia, namely the clarity of 
how a company should implement a CSR 
program- his. From 2009 to 2011. In 2011, as 
many as 16 companies, the average allocation 
of CSR funds was 1.6 percent of company 
profits, for state-owned enterprises the average 
allocation was 2.7 percent of profits, as well as 
for private companies are 0.53 percent of 
profits. Therefore, the role of moderation is 
needed to be able to strengthen the relationship 
between CSR and company values, namely the 
size of the company and profitability. 
Firm size is the size of the total assets of a 
company because total assets are a reflection 
of the company's wealth (Goh & Simanjuntak, 
2018). (Pratama & Wiksuana, 2016) state that 
the greater the company will influence the 
determination of funding to be able to optimize 
company value, stated by (Sofia & Akhmadi, 
2018) that large companies easily access to the 
capital market easily obtain larger funds, so 
that they are able to obtain positive signals 
from investors. (Putri, Sudarma, & 
Purnomosidhi, 2016) and (Puspaningrum, 
2017) shows that the size of the company is 
able to moderate the relationship between 
Corporate Social Responsibility and corporate 
value means that large companies will disclose 
information related to social, economic and 
environmental aspects more because large 
companies tend to do a lot of activities that 
tend to attract investors interest in investing. In 
addition to the size of the company the factors 
that can increase and strengthen the 
relationship of CSR with company value are 
profitability. 
Profitability is the ability of the 
company's management to earn profits. In the 
Signaling Theory stated by (Sofia & Akhmadi, 
2018) that high profitability will give a good 
response from investors because it can increase 
stock prices and increase company value. 
(Humairoh, 2017), who stated that profitability 
was able to moderate the relationship of CSR 
with company value. Because some of the 
company's profits are absorbed for the benefit 
of the program related to corporate social 
responsibility. The absorption of the profits 
obtained by this company can maintain the 
continuity of the company's life based on its 
operations. 
CONCEPT AND HYPOTHESIS 
Company value is market value or related 
to stock prices, securities, capital and debt in 
outstanding companies (Ananda, Hermanto, & 
I Nyoman Nugraha AP, 2016). The value of 
the company increases if the company is able 
to maximize the welfare and prosperity of 
shareholders (Rumajar, 2018). (Putra & 
Wiagustini, 2013) stated that CSR can help in 
increasing company value by reducing 
financial and non-financial information 
asymmetry. To find out the relationship 
between them, the role of moderation is of 
course related to company value factors, 
namely company size and profitability as a 
part that this variable can improve the 
relationship between the two. 
The size of the company or firm size  is 
the size of the company by taking into account 
the total assets as a reflection of the 
development of the company's wealth in 
accordance with company activities. Thus, the 
size of the company is able to strengthen the 
relationship of CSR to the value of the 
company because large companies implement 
various types of activities related to CSR that 
are not only for external companies but for 
internal companies. The size of the company is 
able to moderate the relationship of CSR with 
the value of the company because the company 
provides an opportunity to be able to develop 
in aspects that need to be considered in the 
welfare of society that are not only for the sake 
of the company.  
Increasing profitability raises the 
condition of companies that are at an 
increasing level so that the growth of the 
company will be helped and can attract 
investors in making investments because 
profitability will provide a signal for investors 
through stock demand. Profitability can 
improve CSR because some of the company's 
profits are intended to carry out CSR programs 
as the company's obligation to increase 
company value. Companies with good levels 
of profitability are able to provide stability in 
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carrying out CSR programs because CSR 
programs require funds. 
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Figure 1 
The Effect Of Corporate Social Responsibility On Company Value With Company Size And Profitability As Moderated 
Variables In Pharmaceutical Companies Listed On The Indonesia Stock Exchange  
Based on the explanation above, 
therefore, the hypothesis that can be made are: 
H1 :Corporate Social Responsibility 
significant positive effect on Company Values 
on Pharmaceutical Companies listed on the 
Indonesia Stock Exchange. 
H2 :Size of an influential company 
significant positive effect on Company Values 
on Pharmaceutical Companies listed on the 
Indonesia Stock Exchange. 
H3 :Profitability has a positive effect 
significant value of the Company in 
Pharmaceutical Companies listed on the 
Indonesia Stock Exchange. 
H4 :Company size moderates 
the relationship of Corporate Social 
Responsibility to Company Values in 
Pharmaceutical Companies listed on the 
Indonesia Stock Exchange. 
H5 :Profitability moderates relationships 
Corporate Social Responsibility for Corporate 
Values in Pharmaceutical Companies listed on 
the Indonesia Stock Exchange. 
METHOD 
This study uses a quantitative method 
which uses time series or past data related to 
the Annual Report of Pharmaceutical 
Companies listed on the  Indonesia Stock 
Exchange. The annual report period or 
timeframe is 2014-2017 which can be accessed 
at www.idx.com. The variables in this research 
consist of Corporate Social Responsibility 
(X1), Company size (X2), Profitability (X3), 
and Company Value (Y). 
The formula for corporate value measured 
by Tobin’s Q (Waluyo, 2017). 
  Q =  
Information : 
Q  = Company Value 
MVS = Stock market value 
BVE = Book Value Equity 
D = Debt or Book Value from Total 
    Debt 
Whereas, CSR is calculated as follows 
(Wulandari, 2015). 
CSRIj =  
Information : 
CSRIj  = Disclosure of Corporate Social 
     Corporate Responsibility Index j 
Nj  = Number of items for company j, nj
  =  91 
Xij  = 1 if item i is expressed, 0 = if item i 
is not disclosed 
Profitability measured by using ROA is as 
follows (Nugroho, 2012). 
ROA =  
NIAT = Net Income After Tax (income 
    clean after tax) 
TA = Total Assets 
The target population in this study are 
pharmaceutical companies that go public on 
the Indonesia Stock Exchange with the period 
2014 - 2017. This study uses sample access 
with fairly easy conditions because the data 
obtained through the website and if it is not 
accessible the data cannot be used. There were 
eight pharmaceutical companies which were 
made into this study. The technical data 
analysis in this study uses Moderated 
Regression Analysis. Previously, classical 
assumptions were tested to fulfill the 
Moderated Regression Analysis requirements. 
RESULT AND DISCUSSION 
Classical Assumption Test Model 1 
Classical assumption model 1 to compare 
CSR with firm size against firm value. 
Previously the regression equation was done 
by making it log to minimize the deviation or 
bias. With the regression equation as 
follows.LY1 = bo + b1LX1 + b2LX2 + 
b3LX1.LX2. 
1. Model 1 Normality Test The residual 
values of Z1 and Z2 are 1,208 and 0.108 
and have a significance above the level of 
0.05 so that the model is normally 
distributed. 
2. Model 1 Autocorrelation Test Model 1 dL 
value table (at n = 32 and independent 
variable k = 3) is 1.244 and dU table is 
1.650 while the dw value of the calculated 
result is 1.571. So that it is located in 
criterion two, that is dL <dW <dU or there 
is no conclusion. 
3. Model 1 Muticolenity Test All variables 
contain multicol because of the independent 
variable VIF> 10, this is a common 
occurrence in the case of equations that 
contain interactions (Ghozali, 2016). 
4. Model 1 heterocedasticity test The 
estimation model shows that model 2 forms 
an irregular distribution between regression 
student deleted residuals and regression 
standardized predictive value, meaning that 
it does not contain heteroscedastic. 
Model 1 Regression Analysis 
This model 1 analysis will illustrate the 
interactions that occur between CSR (X1) 
which simultaneously with company size (X2) 
on firm value (Y). With the results that CSR 
has a significant negative effect on the value of 
the company with a regression coefficient of 
80.630 with a significance of 0.003. The size 
of the company has a significant positive effect 
on the value of the company coefficient of 
32.352 significance level of 0.05. The 
interaction of CSR and company size with 
respect to firm value is equal to 59,215 and the 
significance level is smaller than 0.05. These 
results are shown in table 1 as follows. 
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Table 1 
Model 1 Regression Analysis 
Coefficientsa 
Model 
Unstandardized Coefficients 
Standardized 
Coefficients t Sig. 
B Std. Error Beta 
1 
(Constant) -43,059 14,540   -2,961 ,008 
LX1 -80,630 24,351 -15,934 -3,311 ,003 
LX2 32,352 10,378 3,857 3,117 ,005 
X1X2 59,215 17,407 16,598 3,402 ,003 
Moderation Analysis Model 1 
Model 1 Moderation analysis shows that 
the regression coefficient β1 firm value (LY) 
to the value of absolute e1 | e1 | is positive at 
0.219 and significant at the 0.05 level with a 
calculated T value of 2.318 and a Sig value of 
0.030 smaller than p value which is equal to 
0.05. It means that company size variable (X2) 
is not a moderation between Corporate Social 
Responsibility (X1) and firm value (Y). The 
moderation requirements are significantly 
negative. The moderation of model 1 uses the 
residual test shown in table 2 as follows. 
Table 2 
Model 1 Moderation Analyses  
Coefficientsa 
Model 
Unstandardized 
Coefficients 
Standardized 
Coefficients 
t Sig. 
95,0% 
Confidence 
Interval for B 
Correlations 
Collinearity 
Statistics 
B 
Std. 
Error 
Beta 
Lower 
Bound 
Upper 
Bound 
Zero-
order 
Partial Part 
Toleran
ce 
VIF 
1 
(Consta
nt) 
,043 ,101   ,428 ,673 -,167 ,253           
LY ,219 ,094 ,443 2,318 ,030 ,023 ,415 ,443 ,443 ,443 1,000 1,000 
Classical Assumption Test Model 2 
The classic assumption model 2 is to 
compare CSR with profitability against firm 
value. Previously the regression equation was 
done by making it log to minimize the 
deviation or bias. With the regression equation 
as follows. 
LY1 = bo + b1LX1 + b3LX3 + b4LX1.LX3. 
Model 2 Normality Test 
The residual value of model 2 has a value 
of Z1 and Z3 of 0.697 and 0.717 and has a 
significant level above 0.05 so that the model 
is normally distributed. 
Model 2 Autocorrelation Test 
The value of dL in model 2 (at n = 32 and 
independent variable k = 3) is 1.244 and dU 
table is 1.650 while the dW value of the 
calculated result is 1.802. So that it is located 
in criterion 3 which is dU <dW <4 - dU or 
does not contain autocorrelation. 
Model 2 Multicolourity Test 
The LX3 and X1X3 variables contain 
multicol because the value of the independent 
variable VIF> 10, this is a common occurrence 
in the case of equations that contain 
interactions (Ghozali, 2016). 
Model 2 Heterocedasticity Test 
The estimation model 2 shows the form of 
irregular distribution between regression 
studentized residuals and regression 
standardized predictive value, meaning that it 
does not contain heteroscedastic. 
Model 2 Regression Analysis 
The analysis of model 2 will illustrate the 
interactions that occur between CSR (X1) 
which are juxtaposed with profitability (X3) on 
firm value (Y). With the results that CSR has a 
significant positive effect on the value of the 
company with a regression coefficient of 5.519 
on the value of the company a significance 
level of 0.004 is smaller than 0.05. Profitability 
has a significant positive effect on the value of 
the company the coefficient of negative is 
3.845 against the value of the company and the 
relationship has a significance of 0.029 smaller 
than 0.05. The interaction of CSR and 
profitability was -7.194 and significant at the 
0.05 level with respect to company values. The 
results shown in table 3 are as follows. 
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Table 3 
Model 2 Regression Analysis 
Coefficientsa 
Model 
Unstandardized 
Coefficients 
Standardized 
Coefficients 
t Sig. 
B 
Std. 
Error 
Beta 
1 
(Constant) 3,951 1,077   3,670 ,002 
LX1 5,519 1,671 1,141 3,302 ,004 
LX3 -3,845 1,614 -4,034 -2,383 ,029 
X1X3 -7,194 2,641 -4,446 -2,724 ,014 
Moderation Analysis Model 2 
The moderation analysis of Model 2 
shows that the regression coefficient value for 
the effect of firm value on absolute value e2 | 
e2 | is positive 0.164 and not significant at the 
0.05 level with a calculated T value of 2.004 
with a Sig value of 0.060 greater than p value 
which is equal to 0.05. This means that the 
profitability variable (X3) is not a moderation 
between Corporate Social Responsibility (X1) 
and firm value (Y). The moderation analysis of 
model 2 shown in table 4 is as follows. 
Table 4 
Model 2 Moderation Analyses 
Coefficientsa 
Model 
Unstandardize
d Coefficients 
Standardized 
Coefficients 
t Sig. 
95,0% 
Confidence 
Interval for B 
Correlations 
Collinearity 
Statistics 
B 
Std. 
Error 
Beta 
Lower 
Bound 
Upper 
Bound 
Zero-
order 
Partial Part Tolerance VIF 
1 
(Constant) ,094 ,082   1,138 ,269 -,079 ,266           
LY ,164 ,082 ,418 2,004 ,060 -,007 ,335 ,418 ,418 ,418 1,000 1,000 
The Effect of CSR on Company Values 
When interaction with profitability, it will 
produce dominant results, namely Corporate 
Social Responsibility, which has a significant 
positive effect on firm value. If, Corporate 
Social Responsibility is interact with company 
size, the effect is Corporate Social 
Responsibility has a significant negative effect 
on firm value, meaning that companies 
implementing Corporate Social Responsibility 
take at least 0.5% of the profits obtained by 
pharmaceutical companies. So, it can advance 
the Corporate Social Responsibility program 
well in accordance with the company's 
operations. the company can increase the 
concern and welfare of the company in the 
company environment both externally and 
internally which involves three aspects, 
namely social aspects, economic aspects, and 
environmental aspects and build a positive 
image for the community for the company. 
This result is in line with the study of (Susanti, 
Marietsa, & Indriani, 2012); (Wulandari, 
2015); (Humairoh, 2017); Thus CSR has a 
significant positive effect on firm value. So, 
Hypothesis 1 is accepted. 
The Effect of Company Size on Company 
Values. 
The size of the company that is proxied 
by the logarithm of total assets owned by 
pharmaceutical companies is getting higher or 
increasing the assets owned by the company 
are getting better and the value of 
pharmaceutical companies is also shown in the 
increase in total assets of the company from 
2014-2017 to pharmaceutical companies. It is 
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this increase in the size of the company based 
on assets that makes pharmaceutical 
companies able to grow and grow well so that 
they will slowly increase the value of the 
company. So that hypothesis 2 is accepted and 
in line with the research of (Pratama & 
Wiksuana, 2016); (Andawasatya, Indrawati, & 
Aisjah, 2017); (Hamyat, Sarita, & Hasbudin, 
2017); (Sofia & Akhmadi, 2018). 
The Effect of Profitability on Company 
Values 
Profitability has a significant negative 
value on company value, meaning that 
profitability increases, the value of the 
company will tend to decrease. Increased 
profitability is not accompanied by an increase 
in stock prices which has an impact on the 
decline in company value. The company 
focuses on short-term orientation techniques so 
that it can reduce the value of the company. 
Because the value of the company is 
comprehensive, that is long term. Thus the 
third hypothesis in this study was rejected. 
This is supported by (Herawati, 2013); 
(Ananda et al., 2016); and (Thaib & 
Dewantoro, 2017). 
Company Size moderates the relationship of 
CSR to Company Value 
The size of the company cannot moderate 
the relationship of CSR to company value 
because the pharmaceutical company has 
allocated its own funds specifically to fund 
Corporate Social Responsibility, both small 
and large size companies. In addition, the 
indicator of measurement of Corporate Social 
Responsibility using GRI 4 has no limitations 
seen from the size of the company both large 
or small so that to apply the broad disclosure 
of Corporate Social Responsibility to large and 
small pharmaceutical companies with good 
image in the eyes of investors does not become 
the main focus in the company's valuation so 
that it cannot affect the value of the company. 
So, the fourth hypothesis is rejected. This is 
not in line with (Putri et al., 2016); 
(Puspaningrum, 2017); (Kiptoo, Soi, & 
Chepsergon, 2017); (Waluyo, 2017); (Jekwam 
& Hermuningsih, 2018). But this result is 
supported by (Humairoh, 2017); (Sari, 
Wahyudi, & Isnurhadi, 2018) and (Karundeng, 
Nangoi, & Karamoy, 2018). 
Profitability moderates the relationship of 
CSR to Corporate Value 
Profitability cannot moderate the 
relationship between Corporate Social 
Responsibility and company value because the 
Figure 2 
The Influence of Corporate Social Responsibility (CSR), Firm Size and Profitability partially towards Firm Value 
profitability of a company in implementing 
Corporate Social Responsibility influences a 
non-strong relationship with firm value. 
Pharmaceutical companies are still classified 
as economical companies which according to 
in (Wahyuni, 2018) economical companies are 
companies that have high profitability but the 
budget for Corporate Social Responsibility is 
still low. In terms of acquiring company assets, 
it can be said to be good, because the assets 
owned can be increased. But the increase in 
assets also does not guarantee that profits will 
increase because if there is a turnover of 
assets, it will increase but not accompanied by 
an increase in stock prices. This result is not as 
accurate as that of (Ekatah, Samy, Bampton, & 
Haabi, 2011); (Wulandari, 2015); (Nawaiseh, 
Boa, & Zaid, Rezk Abou, El-shohnah, 2015); 
(Humairoh, 2017); (Karundeng et al., 2018). 
So this result rejects the fifth hypothesis. 
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Figure 3 
Company Size and Profitability cannot moderate the relationship between Corporate Social Responsibility (CSR) and 
Corporate Value 
CONCLUSIONS  
Corporate Social Responsibility has a 
significant positive effect on company value in 
pharmaceutical companies listed on the 
Indonesia Stock Exchange in 2014-2017. The 
size of the company has a significant positive 
effect on the value of the company in the 
pharmaceutical companies listed on the 
Indonesia Stock Exchange in 2014-2017. 
Profitability has a significant negative effect 
on company value in pharmaceutical 
companies listed on the Indonesia Stock 
Exchange in 2014-2017. The size of the 
company is not able to moderate the 
relationship between Corporate Social 
Responsibility (CSR) and company value in 
pharmaceutical companies listed on the 
Indonesia Stock Exchange in 2014-2017. 
Profitability is not able to moderate the 
relationship between Corporate Social 
Responsibility (CSR) and company value to 
pharmaceutical companies listed on the 
Indonesia Stock Exchange in 2014-2017. 
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